Skip to content
TRENDING:
Donald Trump
Advertisement

Tom Howell Jr.

Tom Howell Jr.

Tom Howell Jr. covers politics and the White House for The Washington Times. He can be reached at thowell@washingtontimes.com.

Articles by Tom Howell Jr.

A medical worker injects a woman with vaccine from Moderna against the coronavirus and the COVID-19 disease in Gera, Germany, Sunday, Nov. 21, 2021. (Bodo Schackow/dpa via AP)

Europe sees COVID-19 chaos amid new lockdowns

A top official said Monday that Germans will be "vaccinated, cured or dead" by the end of winter as Europe scrambles to stem another wave of the coronavirus at the start of the Christmas season, sparking a cycle of restrictions and raucous protests. Published November 22, 2021

President Joe Biden walks to the Oval Office of the White House after arriving on Marine One in Washington, Sunday, Nov. 21, 2021, as he returns from Wilmington, Del. (AP Photo/Carolyn Kaster)

Biden briefed on Wisconsin parade tragedy

President Biden has been briefed about the parade tragedy in Wisconsin and will receive regular updates, the White House said Monday as law enforcement in Waukesha tried to unravel why a sport utility vehicle barreled into the parade-goers, killing five. Published November 22, 2021

In this Thursday, Sept. 2, 2021, file photo, a funeral director arranges flowers on a casket before a service in Tampa, Fla. According to a study published Thursday, Oct. 7, 2021, by the medical journal Pediatrics, the number of U.S. children orphaned during the COVID-19 pandemic may be larger than previously estimated, and the toll has been far greater among Black and Hispanic Americans. (AP Photo/Chris O'Meara, File)

More COVID-19 deaths in 2021 than 2020

COVID-19 killed more people in this calendar year than in 2020, according to federal data that shows the staying power of the virus despite the advent of vaccines nearly a year ago. Published November 22, 2021

A syringe is prepared with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading, Pa., on Sept. 14, 2021. U.S. regulators have opened up COVID-19 booster shots to all and more adults, Friday, Nov. 19, letting them choose another dose of either the Pfizer or Moderna vaccine. (AP Photo/Matt Rourke, File)

FDA authorizes Pfizer-BioNTech and Moderna COVID-19 boosters for all adults

The Food and Drug Administration on Friday approved COVID-19 booster shots from Pfizer-BioNTech and Moderna for all adults, opening a new chapter in the vaccine rollout and allowing the Biden administration to catch up to states that advised residents to seek an extra dose regardless of eligibility. Published November 19, 2021

A staff member of the relief organisation Malteser prepares syringes with the Moderna vaccine against the coronavirus and the COVID-19 disease at a vaccination bus in Unterschleissheim, Germany, Thursday, Nov. 18, 2021. Germany's disease control agency, the The Robert Koch Institute, reported 65,371 new daily cases, shattering the previous 24-hour record and continuing an upward trend that experts have warned about for weeks. (Sven Hoppe/dpa via AP)

Health groups to companies: Implement the OSHA vaccine rule on your own

The American Medical Association and dozens of health care groups urged large companies Thursday to begin implementing President Biden's vaccinate-or-test mandate voluntarily, saying the U.S. cannot afford to delay while the regulation is fought in the courts. Published November 18, 2021

President Joe Biden walks on the South Lawn of the White House in Washington, Wednesday, Nov. 17, 2021, after returning from a trip to Michigan where he promoted the bipartisan infrastructure deal. (AP Photo/Susan Walsh)

Biden buys 10M courses of Pfizer COVID pill

President Biden said Thursday the government has purchased 10 million courses of a Pfizer pill to treat COVID-19 but argued that vaccination remains the nation's "strongest tool" against the pandemic. Published November 18, 2021

Alex Lewandowski prepares a dose of a Moderna COVID-19 vaccine on Thursday, Nov. 4, 2021, at a vaccine center in Barboursville, W.Va. (Sholten Singer/The Herald-Dispatch via AP) ** FILE **

Moderna seeks approval of COVID-19 booster for all adults

Drugmaker Moderna says it asked the Food and Drug Administration to approve its COVID-19 booster shot for all adults, hoping not to be left behind as regulators prepare to offer a third dose of the Pfizer-BioNTech vaccine to everyone over 18. Published November 18, 2021

President Joe Biden speaks about COVID-19 vaccinations after touring a Clayco Corporation construction site for a Microsoft data center in Elk Grove Village, Ill., Thursday, Oct. 7, 2021. The fate of Biden’s vaccine mandate for larger private employers may come down to a lottery that determines which federal circuit court will consider the matter. Conservative groups have filed challenges to the rule in right-leaning courts, while unions that argue the rule doesn’t go far enough have done so in left-leaning courts. The multiple cases are expected to be consolidated, and it will be up to a random drawing — expected on Tuesday, Nov. 16 — to determine where that will be. (AP Photo/Susan Walsh) **FILE**

OSHA has ‘suspended activities’ related to Biden’s vaccine mandate

The Occupational Safety and Health Administration has suspended work on President Biden's vaccine mandate after a federal appeals court hit pause on rules that would force companies with 100 or more employees to require COVID-19 shots or regular testing. Published November 17, 2021

The Pfizer logo is displayed at the company's headquarters in New York, on Feb. 5, 2021. In a statement on Tuesday, Nov. 16, 2021, drugmaker Pfizer Inc. said it has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental coronavirus pill, in a move that could make its treatment available to more than half of the world’s population. (AP Photo/Mark Lennihan, File)

Pfizer inks licensing deal to extend the reach of COVID-19 pill

Pfizer said Tuesday it signed an agreement to license its experimental pill for COVID-19 to qualified generic makers, potentially expanding its reach to countries that account for more than half of the global population. Published November 16, 2021